Somatic diversification of immune receptors via somatic mutation

pathway activity — cross-omics
GO:0002566Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Somatic diversification of immune receptors via somatic mutation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are NEK2, CDCA8, and MCM5, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Somatic diversification of immune receptors via somatic mutation activity versus NEK2 in BRCA (Pearson r = 0.27).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCANEK2 →+1.212+0.847<.001<.00136
BRCACDCA8 →+1.190+0.935<.001<.00136
HNSCMCM5 →+0.684+0.181.001.00135
BRCAE2F1 →+1.203+0.649<.001.00235
BRCAASF1B →+1.071+0.677<.001.00135
HNSCMCM3 →+0.707+0.158.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002566 vs NEK2 — BRCA

Per-sample scatter of Somatic diversification of immune receptors via somatic mutation activity vs NEK2 in BRCA.

Explore this scatter interactively →

Exploration